申请人:Tung S. Jay
公开号:US20060217362A1
公开(公告)日:2006-09-28
Disclosed are compounds that are bradykinin B
1
receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B
1
receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.
揭示了一些化合物,它们是激肽酶B1受体拮抗剂,可用于治疗哺乳动物中由激肽酶B1受体介导的疾病,或缓解与疾病状况相关的不良症状。其中某些化合物表现出增强的效力,并且预计还将表现出延长的作用持续时间。